Aziyo Biologics (ELUT)
NASDAQ:ELUT
US Market
Holding ELUT?
Track your performance easily

Aziyo Biologics (ELUT) Ownership - Who Owns Aziyo Biologics?

54 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 01, 2024
Highcape Capital, L.p.
Director, >10% Owner
xxxxxxxxxxxxx
$2984239
Aug 01, 2024
xxxxxxxxxxxxx
$2984239

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
490,905Institution1.65%1,894,893
485,506Institution1.63%1,874,053
114,614Institution0.39%442,410
24,900Institution0.08%96,114
24,508Institution0.08%94,601
5,000Institution0.02%19,300

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
485,506Institution1.63%1,874,053
114,614Institution0.39%442,410
24,900Institution0.08%96,114
5,000Institution0.02%19,300

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
327,330Institution1.10%1,194,755
163,575Institution0.55%597,049
24,508Institution0.08%94,601

FAQ

Who Owns Aziyo Biologics (ELUT)?
Currently, no data Available
What percentage of Aziyo Biologics (ELUT) stock is held by institutional investors?
Currently, no data Available
What percentage of Aziyo Biologics (ELUT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Aziyo Biologics (ELUT)?
Vanguard owns the most shares of Aziyo Biologics (ELUT).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis